Endo USA, Inc.

Form 483 issued April 15, 2019 · Rochester, Michigan

Inspection
Apr 8 – Apr 15, 2019
Observations
1
Pages
2
FEI number
1818977

In short: On April 15, 2019, FDA issued a Form 483 with 1 observation to Endo USA, Inc. in Rochester, Michigan (FEI 1818977) after an inspection that ran Apr 8 – Apr 15, 2019. The investigators were Amy S. Graf, Joseph T. Madak, Sarah E. Rhoades and Shirshendu K. Deb. Most observations concern production; the most-cited regulation is 21 CFR 211.188 (batch production and control records).

At a glance

1 of 1 observations on this 483 concern production.

Production1

Most cited: 21 CFR 211.188(b) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    The batch production and control records are deficient in that they do not include documentation of…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Endo USA, Inc.?

FDA listed 1 observation on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.188 (batch production and control records). The opening words of each observation are shown on this page.

Who inspected Endo USA, Inc.?

Amy S. Graf, Joseph T. Madak, Sarah E. Rhoades and Shirshendu K. Deb are named on this Form 483, for the inspection of Apr 8 – Apr 15, 2019. Each investigator has a profile showing what they cite most.

When was Endo USA, Inc. inspected by FDA?

The inspection ran Apr 8 – Apr 15, 2019, and the Form 483 is dated April 15, 2019.

How do I get the full Form 483 for Endo USA, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free